Page last updated: 2024-09-05

succinobucol and tranilast

succinobucol has been researched along with tranilast in 2 studies

Compound Research Comparison

Studies
(succinobucol)
Trials
(succinobucol)
Recent Studies (post-2010)
(succinobucol)
Studies
(tranilast)
Trials
(tranilast)
Recent Studies (post-2010) (tranilast)
5351658328197

Protein Interaction Comparison

ProteinTaxonomysuccinobucol (IC50)tranilast (IC50)
Multidrug resistance-associated protein 4Homo sapiens (human)1

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grégoire, J; L'Allier, PL; Lavoie, MA; Tardif, JC1
Douglas, JS1

Reviews

2 review(s) available for succinobucol and tranilast

ArticleYear
Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
    Current opinion in lipidology, 2003, Volume: 14, Issue:6

    Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; ortho-Aminobenzoates; Oxidative Stress; Probucol; Sirolimus; Vitamins

2003
Pharmacologic approaches to restenosis prevention.
    The American journal of cardiology, 2007, Sep-03, Volume: 100, Issue:5A

    Topics: Angioplasty, Balloon, Coronary; Cilostazol; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Humans; ortho-Aminobenzoates; Pioglitazone; Platelet Aggregation Inhibitors; Probucol; Risk Factors; Stents; Tetrazoles; Thiazolidinediones; Trapidil; Treatment Outcome

2007